<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="editorial"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ear Nose Throat J</journal-id><journal-id journal-id-type="iso-abbrev">Ear Nose Throat J</journal-id><journal-id journal-id-type="publisher-id">EAR</journal-id><journal-id journal-id-type="hwp">spear</journal-id><journal-title-group><journal-title>Ear, Nose, &#x00026; Throat Journal</journal-title></journal-title-group><issn pub-type="ppub">0145-5613</issn><issn pub-type="epub">1942-7522</issn><publisher><publisher-name>SAGE Publications</publisher-name><publisher-loc>Sage CA: Los Angeles, CA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7453155</article-id><article-id pub-id-type="doi">10.1177/0145561320950491</article-id><article-id pub-id-type="publisher-id">10.1177_0145561320950491</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group></article-categories><title-group><article-title>Safety and Impact of Nasal Lavages During Viral Infections Such as SARS-CoV-2</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5939-5372</contrib-id><name><surname>Radulesco</surname><given-names>Thomas</given-names></name><degrees>MD, PhD, MS</degrees><xref ref-type="aff" rid="aff1-0145561320950491">1</xref><xref ref-type="aff" rid="aff2-0145561320950491">2</xref><xref ref-type="corresp" rid="corresp1-0145561320950491"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0845-0845</contrib-id><name><surname>Lechien</surname><given-names>Jerome R.</given-names></name><degrees>MD, PhD, MS</degrees><xref ref-type="aff" rid="aff1-0145561320950491">1</xref><xref ref-type="aff" rid="aff3-0145561320950491">3</xref><xref ref-type="aff" rid="aff4-0145561320950491">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3655-1854</contrib-id><name><surname>Saussez</surname><given-names>Sven</given-names></name><degrees>MD, PhD, MS</degrees><xref ref-type="aff" rid="aff3-0145561320950491">3</xref></contrib><contrib contrib-type="author"><name><surname>Hopkins</surname><given-names>Claire</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff5-0145561320950491">5</xref></contrib><contrib contrib-type="author"><name><surname>Michel</surname><given-names>Justin</given-names></name><degrees>MD, PhD, MS</degrees><xref ref-type="aff" rid="aff1-0145561320950491">1</xref><xref ref-type="aff" rid="aff2-0145561320950491">2</xref></contrib></contrib-group><aff id="aff1-0145561320950491">
<label>1</label>COVID-19 Task Force of the Young-Otolaryngologists of the International Federations of Otorhinolaryngological Societies (YO-IFOS), Marseille, France</aff><aff id="aff2-0145561320950491">
<label>2</label>Department of Otorhinolaryngology&#x02013;Head and Neck Surgery, Aix Marseille University, <institution-wrap><institution-id institution-id-type="Ringgold">36900</institution-id><institution content-type="university">APHM, IUSTI, La Conception University Hospital</institution></institution-wrap>, Marseille, France</aff><aff id="aff3-0145561320950491">
<label>3</label>Department of Human Anatomy and Experimental Oncology, Faculty of Medicine, UMONS Research Institute for Health Sciences and Technology, <institution-wrap><institution-id institution-id-type="Ringgold">54521</institution-id><institution content-type="university">University of Mons (UMons)</institution></institution-wrap>, Mons, Belgium</aff><aff id="aff4-0145561320950491">
<label>4</label>Department of Otolaryngology&#x02013;Head &#x00026; Neck Surgery, Foch Hospital, School of Medicine, UFR Simone Veil, Universit&#x000e9; Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France</aff><aff id="aff5-0145561320950491">
<label>5</label><institution-wrap><institution-id institution-id-type="Ringgold">4820</institution-id><institution content-type="university">King&#x02019;s College</institution></institution-wrap>, London</aff><author-notes><corresp id="corresp1-0145561320950491">Thomas Radulesco, MD, PhD, MS, Department of Otorhinolaryngology&#x02013;Head and Neck Surgery, La Conception University Hospital, 147 Bd Baille, 13005 Marseille, France. Email: <email>thomas.radulesco@ap-hm.fr</email></corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>8</month><year>2020</year></pub-date><elocation-id>0145561320950491</elocation-id><history><date date-type="received"><day>20</day><month>7</month><year>2020</year></date><date date-type="rev-recd"><day>23</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>27</day><month>7</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder content-type="sage">SAGE Publications</copyright-holder><license license-type="creative-commons" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"><license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><kwd-group><kwd>nasal lavages</kwd><kwd>SARS-CoV-2</kwd><kwd>viruses</kwd><kwd>viral load</kwd><kwd>coronavirus infections</kwd><kwd>pandemics</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>edited-state</meta-name><meta-value>corrected-proof</meta-value></custom-meta><custom-meta><meta-name>typesetter</meta-name><meta-value>ts3</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>Much has been stated about the potential risks of nasal lavages (NL) during the coronavirus disease 2019 (COVID-19) pandemic for COVID-19 patients and surrounding people. Several otolaryngological societies recommended to limit NL, supposing it may be associated with viral spread to lower airway.<sup><xref rid="bibr1-0145561320950491" ref-type="bibr">1</xref></sup> On the contrary, recent studies suggested that NL may be beneficial in upper viral respiratory infectious diseases. In order to take stock of this issue, we conducted a short literature review to address 4 main questions:</p><sec disp-level="2" id="section1-0145561320950491"><title>What Are the Potential Benefits of NL to COVID-19 Patients?</title><sec id="section2-0145561320950491"><title>Beneficial effects on nasal mucosal</title><p>Ions, pH and tonicity may influence epithelial cell function in vitro. Isotonic solutions with slightly alkaline pH optimize trophic and functional recovery of the respiratory epithelium.<sup><xref rid="bibr2-0145561320950491" ref-type="bibr">2</xref></sup> In chronic rhinosinusitis, saline solutions improve mucociliary clearance<sup><xref rid="bibr3-0145561320950491" ref-type="bibr">3</xref></sup> without altering commensal bacteria.<sup><xref rid="bibr4-0145561320950491" ref-type="bibr">4</xref></sup> These actions may aid recovery of the nasal epithelium after viral injury and reduce associated symptoms of rhinitis.</p></sec><sec id="section3-0145561320950491"><title>Direct antiviral effects</title><p>Recently, Ramalingam et al reported that antiviral activity against viral infections can be augmented by increasing availability of NaCl.<sup><xref rid="bibr5-0145561320950491" ref-type="bibr">5</xref></sup> Nasal lavages containing carrageenans, which are natural emulsifiers derived from red seaweed, seemed to reduce the Influenza A viral load in nasal secretions and positive effects on mucosal barrier function.<sup><xref rid="bibr6-0145561320950491" ref-type="bibr">6</xref>,<xref rid="bibr7-0145561320950491" ref-type="bibr">7</xref></sup> Hendley and Gwaltney reported lower virus concentrations after saline NL in <italic>rhinovirus</italic> infections.<sup><xref rid="bibr8-0145561320950491" ref-type="bibr">8</xref></sup> Regarding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Carrouel et al found the use of a mouth rinses with local nasal applications that contain &#x003b2;-cyclodextrins combined with flavonoids agents reduce the viral load of saliva and nasopharyngeal microbiota, including potential SARS-CoV-2 carriage.<sup><xref rid="bibr9-0145561320950491" ref-type="bibr">9</xref></sup>
</p><p>The use of copper-enhanced NL seems to be efficient to decrease viral spread and contamination, especially regarding SARS-CoV-2.<sup><xref rid="bibr10-0145561320950491" ref-type="bibr">10</xref>,<xref rid="bibr11-0145561320950491" ref-type="bibr">11</xref></sup> Human coronavirus 229E was rapidly inactivated on a range of copper alloys at low copper concentration, suggesting a specific antiviral effect.<sup><xref rid="bibr12-0145561320950491" ref-type="bibr">12</xref>,<xref rid="bibr13-0145561320950491" ref-type="bibr">13</xref></sup> In fact, exposure to copper destroyed the viral genomes and irreversibly affected virus morphology, including disintegration of envelope and dispersal of surface spikes.<sup><xref rid="bibr14-0145561320950491" ref-type="bibr">14</xref></sup> Copper also inactivates SARS coronavirus, bacteria, and yeast in the air after 20 minutes of exposure.<sup><xref rid="bibr15-0145561320950491" ref-type="bibr">15</xref></sup> A recent study has proposed that the combination of copper, N-acetylcysteine, colchicine, and nitric oxide with antiviral agents may be a treatment option for SARS-CoV-2-positive patients.<sup><xref rid="bibr16-0145561320950491" ref-type="bibr">16</xref></sup>
</p></sec><sec id="section4-0145561320950491"><title>Washing and reduction of viral load in enhancing recovery</title><p>Computational fluid dynamics studies demonstrate that all nasal regions are reached when using a head tilt position of 45 &#x000b0;C forward for NL,<sup><xref rid="bibr17-0145561320950491" ref-type="bibr">17</xref></sup> especially with large-volume irrigations,<sup><xref rid="bibr18-0145561320950491" ref-type="bibr">18</xref></sup> suggesting good mechanical efficiency of NL in washing the nose.</p><p>Nasal mucosa have high viral loads and include cells expressing proteases responsible for virus entry (such as angiotensin-converting enzyme 2 and TMPRSS2 for SARS-CoV-2),<sup><xref rid="bibr19-0145561320950491" ref-type="bibr">19</xref>,<xref rid="bibr20-0145561320950491" ref-type="bibr">20</xref></sup> The upper airway has shown to be a reservoir for descending bacterial or viral infection to the lung.<sup><xref rid="bibr21-0145561320950491" ref-type="bibr">21</xref></sup> The nose can be considered as a site of virus replication, accumulation, and human body entry.<sup><xref rid="bibr22-0145561320950491" ref-type="bibr">22</xref></sup> Interestingly, NL tends to decrease nasal viral loads and, therefore, could reduce systemic or bronchopulmonary dissemination.<sup><xref rid="bibr8-0145561320950491" ref-type="bibr">8</xref></sup> Nasal lavages are commonly used treatments in the upper respiratory tract infections and can decrease duration of illness in common cold.<sup><xref rid="bibr3-0145561320950491" ref-type="bibr">3</xref>,<xref rid="bibr23-0145561320950491" ref-type="bibr">23</xref>,<xref rid="bibr24-0145561320950491" ref-type="bibr">24</xref></sup>
</p><p>Given the potential benefits summarized above, nasal saline irrigation may enhance recovery in patients known to be infected with COVID-19. Patients are currently being recruited to a randomized controlled trial to evaluate the benefits to COVID-19 patients, although no results are yet available.<sup><xref rid="bibr25-0145561320950491" ref-type="bibr">25</xref></sup>
</p></sec></sec><sec disp-level="2" id="section5-0145561320950491"><title>What Are the Potential Benefits of NL to Personal Contacts/Healthcare Workers Caring for COVID-19 Patients?</title><p>When properly performed, NL have shown to decrease household transmission in other viral disease.<sup><xref rid="bibr26-0145561320950491" ref-type="bibr">26</xref></sup> The potential direct antiviral actions and reduction in viral load have led to proposals that use in patients with COVID-19 may reduce risk of nosocomial transmission. It has been proposed that regular use of NL in COVID-19 patients may reduce risk of transmission to household contacts or Healthcare Workers (HCWs), particularly if used before aerosol-generating procedures (AGPs).<sup><xref rid="bibr27-0145561320950491" ref-type="bibr">27</xref></sup> It has also been suggested that HCWs involved in the care of COVID-19 patients could use NL with povidone&#x02013;iodine before and after patient contact, particularly for high-risk procedures.<sup><xref rid="bibr27-0145561320950491" ref-type="bibr">27</xref></sup>
</p><p>In asking a patient or currently healthy HCW to perform an intervention aimed at protecting others, it is important to discuss potential side effects of the intervention.</p></sec><sec disp-level="2" id="section6-0145561320950491"><title>What Are the Potential Harms of NL to Patients With COVID-19?</title><sec id="section7-0145561320950491"><title>Risk of toxicity</title><p>Although nasal saline irrigation has been shown to have no detrimental effects on olfaction, additives to NL solutions may cause anosmia, which would be difficult to detect in trials of COVID-19 patients, where olfactory dysfunction is highly prevalent. A number of agents have been shown to cause anosmia if delivered intranasally, such as zinc gluconate and sinus surfactant solutions.<sup><xref rid="bibr28-0145561320950491" ref-type="bibr">28</xref></sup> Although the safety of povidone&#x02013;iodine has been evaluated in vitro, at concentrations above 5% it is known to be ciliotoxic.<sup><xref rid="bibr29-0145561320950491" ref-type="bibr">29</xref></sup> Its use in mouthwash and nasal spray in COVID-19-infected patients prior to dental and other AGPs has been widely promoted in the absence of rigorous in vivo evaluation.<sup><xref rid="bibr7-0145561320950491" ref-type="bibr">7</xref>,<xref rid="bibr30-0145561320950491" ref-type="bibr">30</xref></sup>
</p></sec><sec id="section8-0145561320950491"><title>Risk of bronchopulmonary dissemination</title><p>To date, no study suggested that NL is associated with lower respiratory disorders.</p></sec></sec><sec disp-level="2" id="section9-0145561320950491"><title>What Are the Potential Harms of NL to Personal Contacts/HCWs Caring For COVID-19 Patients?</title><sec id="section10-0145561320950491"><title>Risk of droplet spread and surface contamination</title><p>Irrigation is likely to generate droplets potentially carrying viruses. Sinus irrigation devices, mostly composed by plastic, can harbor viruses for hours: van Doremalen et al showed that SARS-CoV-2 is very stable on plastic and remains viable up to 72 hours.<sup><xref rid="bibr12-0145561320950491" ref-type="bibr">12</xref></sup> As the COVID-19 status of most of patients using NL is unknown, specific measures should be undertaken to protect personal contacts or HCWs.<sup><xref rid="bibr31-0145561320950491" ref-type="bibr">31</xref></sup>
</p></sec><sec id="section11-0145561320950491"><title>Protective measures</title><list list-type="simple"><list-item><p>&#x02013; Clean the inside and outside of the NL device thoroughly with soap and water. For a deeper clean of components of the device that come into contact with the nose, clean with 70% isopropyl alcohol or concentrated white vinegar, rinse, and then leave to it dry before next use. Some commercial products may be suitable for sterilization in the microwave but must be replaced if there is any sign of degradation of plastic components.</p></list-item><list-item><p>&#x02013; Self-irrigation is important, avoiding viral exposure to others.</p></list-item><list-item><p>&#x02013; Ventilate the room: being able to remain suspended in the air, small droplets were shown to permit SARS-CoV-2 detection in ambient air for 3 hours.<sup><xref rid="bibr12-0145561320950491" ref-type="bibr">12</xref></sup> Guidelines on air exchanges per hour required for airborne contaminant removal have been edited by CDC.<sup><xref rid="bibr32-0145561320950491" ref-type="bibr">32</xref></sup>
</p></list-item><list-item><p>&#x02013; Perform household cleaning, disinfection of high-touch surfaces, and hand hygiene. The United States Environmental Protection Agency and the CDC (Center for Disease Control and Prevention) published a list of recommended household disinfectants.<sup><xref rid="bibr33-0145561320950491" ref-type="bibr">33</xref></sup>
</p></list-item></list><p>Consistent with current guidance, these measures will help to limit viral spreading.</p></sec></sec><sec sec-type="conclusions" id="section12-0145561320950491"><title>Conclusion</title><p>Taken together, these data suggest that NL can be continued during viral infection when respecting strict conditions of use and hygienic measures. Moreover, properly performed, large-volume NL with specific composition such as copper or povidone&#x02013;iodine could limit viral contamination and spreading. In vitro, in vivo, and in silico studies must confirm these data.</p></sec></body><back><fn-group><fn fn-type="other" id="fn1-0145561320950491"><p><bold>Authors&#x02019; Note:</bold> T.R. and J.R.L. are joint first authors. C.H. and J.M. are joint senior authors.</p></fn></fn-group><ack><title>Acknowledgments</title><p>To Pr Vincent Couloigner and Dr Philippe Contencin.</p></ack><fn-group><fn fn-type="COI-statement" id="fn2-0145561320950491"><p><bold>Declaration of Conflicting Interests:</bold> The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></fn><fn fn-type="financial-disclosure" id="fn3-0145561320950491"><p><bold>Funding:</bold> The author(s) received no financial support for the research, authorship, and/or publication of this article.</p></fn><fn fn-type="other" id="fn4-0145561320950491"><p><bold>ORCID iDs:</bold> Thomas Radulesco <inline-graphic xlink:href="10.1177_0145561320950491-img1.jpg"/>
<ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-5939-5372">https://orcid.org/0000-0002-5939-5372</ext-link>
</p><p>Jerome R. Lechien <inline-graphic xlink:href="10.1177_0145561320950491-img1.jpg"/>
<ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-0845-0845">https://orcid.org/0000-0002-0845-0845</ext-link>
</p><p>Sven Saussez <inline-graphic xlink:href="10.1177_0145561320950491-img1.jpg"/>
<ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-3655-1854">https://orcid.org/0000-0002-3655-1854</ext-link>
</p></fn></fn-group><ref-list><title>References</title><ref id="bibr1-0145561320950491"><label>1</label><mixed-citation publication-type="web">
<comment>CONSULTATIONS ET TRAITEMENTS MEDICAMENTEUX EN RHINOLOGIE EN CONTEXTE D&#x02019;EPIDEMIE COVID-19. 2020</comment>
<comment>Accessed July 15, 2020</comment>
<ext-link ext-link-type="uri" xlink:href="https://www.sforl.org/wp-content/uploads/2020/03/AFR-SFORL-COVID-19-V2.pdf">https://www.sforl.org/wp-content/uploads/2020/03/AFR-SFORL-COVID-19-V2.pdf</ext-link>.</mixed-citation></ref><ref id="bibr2-0145561320950491"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bastier</surname><given-names>PL</given-names></name><name><surname>Lechot</surname><given-names>A</given-names></name><name><surname>Bordenave</surname><given-names>L</given-names></name><name><surname>Durand</surname><given-names>M</given-names></name><name><surname>de Gabory</surname><given-names>L</given-names></name></person-group>
<article-title>Nasal irrigation: from empiricism to evidence-based medicine. A review</article-title>. <source>Eur Ann Otorhinolaryngol Head Neck Dis</source>. <year>2015</year>;<volume>132</volume>(<issue>5</issue>):<fpage>281</fpage>&#x02013;<lpage>285</lpage>.<pub-id pub-id-type="pmid">26344138</pub-id></mixed-citation></ref><ref id="bibr3-0145561320950491"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de Gabory</surname><given-names>L</given-names></name><name><surname>Escabasse</surname><given-names>V</given-names></name><name><surname>Boudard</surname><given-names>P</given-names></name></person-group>, <etal>et al.</etal>
<article-title>Prospective, randomized, controlled, open-label study to compare efficacy of a mineral-rich solution vs normal saline after complete ethmoidectomy</article-title>. <source>Eur Arch Otorhinolaryngol</source>. <year>2019</year>;<volume>276</volume>(<issue>2</issue>):<fpage>447</fpage>&#x02013;<lpage>457</lpage>.<pub-id pub-id-type="pmid">30536161</pub-id></mixed-citation></ref><ref id="bibr4-0145561320950491"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>CM</given-names></name><name><surname>Kohanski</surname><given-names>MA</given-names></name><name><surname>Mendiola</surname><given-names>M</given-names></name></person-group>, <etal>et al.</etal>
<article-title>Impact of saline irrigation and topical corticosteroids on the postsurgical sinonasal microbiota: topical therapies and the sinonasal microbiota</article-title>. <source>Int Forum Allergy Rhinol</source>. <year>2015</year>;<volume>5</volume>(<issue>3</issue>):<fpage>185</fpage>&#x02013;<lpage>190</lpage>.<pub-id pub-id-type="pmid">25556553</pub-id></mixed-citation></ref><ref id="bibr5-0145561320950491"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ramalingam</surname><given-names>S</given-names></name><name><surname>Cai</surname><given-names>B</given-names></name><name><surname>Wong</surname><given-names>J</given-names></name></person-group>, <etal>et al.</etal>
<article-title>Antiviral innate immune response in non-myeloid cells is augmented by chloride ions via an increase in intracellular hypochlorous acid levels</article-title>. <source>Sci Rep</source>. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>13630</fpage>
<comment>doi:10.1038/s41598-018-31936-y</comment>
<pub-id pub-id-type="pmid">30206371</pub-id></mixed-citation></ref><ref id="bibr6-0145561320950491"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leibbrandt</surname><given-names>A</given-names></name><name><surname>Meier</surname><given-names>C</given-names></name><name><surname>K&#x000f6;nig-Schuster</surname><given-names>M</given-names></name></person-group>, <etal>et al.</etal>
<article-title>Iota-carrageenan is a potent inhibitor of influenza A virus infection</article-title>. <source>PLoS One</source>. <year>2010</year>;<volume>5</volume>(<issue>12</issue>):<fpage>e14320</fpage>
<comment>doi:10.1371/journal.pone.0014320</comment>
<pub-id pub-id-type="pmid">21179403</pub-id></mixed-citation></ref><ref id="bibr7-0145561320950491"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ramezanpour</surname><given-names>M</given-names></name><name><surname>Murphy</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>JLP</given-names></name><name><surname>Vreugde</surname><given-names>S</given-names></name><name><surname>Psaltis</surname><given-names>AJ</given-names></name></person-group>
<article-title>In vitro safety evaluation of human nasal epithelial cell monolayers exposed to carrageenan sinus wash</article-title>. <source>Int Forum Allergy Rhinol</source>. <year>2017</year>;<volume>7</volume>(<issue>12</issue>):<fpage>1170</fpage>&#x02013;<lpage>1177</lpage>. <comment>doi:10.1002/alr.22021</comment>
<pub-id pub-id-type="pmid">29024522</pub-id></mixed-citation></ref><ref id="bibr8-0145561320950491"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hendley</surname><given-names>JO</given-names></name><name><surname>Gwaltney</surname><given-names>JM</given-names></name></person-group>
<article-title>Viral titers in nasal lining fluid compared to viral titers in nasal washes during experimental rhinovirus infection</article-title>. <source>J Clin Virol</source>. <year>2004</year>;<volume>30</volume>(<issue>4</issue>):<fpage>326</fpage>&#x02013;<lpage>328</lpage>.<pub-id pub-id-type="pmid">15163422</pub-id></mixed-citation></ref><ref id="bibr9-0145561320950491"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carrouel</surname><given-names>F</given-names></name><name><surname>Conte</surname><given-names>MP</given-names></name><name><surname>Fisher</surname><given-names>J</given-names></name></person-group>, <etal>et al.</etal>
<article-title>COVID-19: a recommendation to examine the effect of mouthrinses with &#x003b2;-cyclodextrin combined with citrox in preventing infection and progression</article-title>. <source>J Clin Med</source>. <year>2020</year>;<volume>9</volume>(<issue>4</issue>):<fpage>1126</fpage>.</mixed-citation></ref><ref id="bibr10-0145561320950491"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Constant</surname><given-names>S</given-names></name><name><surname>De Servi</surname><given-names>B</given-names></name></person-group>, <etal>et al.</etal>
<article-title>In vitro safety and performance evaluation of a seawater solution enriched with copper, hyaluronic acid, and eucalyptus for nasal lavage</article-title>. <source>Med Devices (Auckl)</source>. <volume>2019</volume>;<issue>12</issue>:<fpage>399</fpage>&#x02013;<lpage>410</lpage>.</mixed-citation></ref><ref id="bibr11-0145561320950491"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Radulesco</surname><given-names>T</given-names></name><name><surname>Lechien</surname><given-names>JR</given-names></name><name><surname>Chiesa-Estomba</surname><given-names>CM</given-names></name></person-group>, <etal>et al.</etal>
<article-title>Copper enhanced nasal saline irrigations: a safe potential treatment and protective factor for COVID-19 infection?</article-title>
<source>Rhinol Online</source>. <year>2020</year>;<volume>3</volume>(<issue>3</issue>):<fpage>87</fpage>&#x02013;<lpage>88</lpage>.</mixed-citation></ref><ref id="bibr12-0145561320950491"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van Doremalen</surname><given-names>N</given-names></name><name><surname>Bushmaker</surname><given-names>T</given-names></name><name><surname>Morris</surname><given-names>DH</given-names></name></person-group>, <etal>et al.</etal>
<article-title>Aerosol and surface stability of SARS-CoV-2 as Compared with SARS-CoV-1</article-title>. <source>N Engl J Med</source>. <year>2020</year>;<volume>382</volume>(<issue>16</issue>):<fpage>1564</fpage>&#x02013;<lpage>1567</lpage>. <comment>doi:10.1056/NEJMc2004973</comment>
<pub-id pub-id-type="pmid">32182409</pub-id></mixed-citation></ref><ref id="bibr13-0145561320950491"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Borkow</surname><given-names>G</given-names></name><name><surname>Gabbay</surname><given-names>J</given-names></name></person-group>
<article-title>Copper as a biocidal tool</article-title>. <source>Curr Med Chem</source>. <year>2005</year>;<volume>12</volume>(<issue>18</issue>):<fpage>2163</fpage>&#x02013;<lpage>2175</lpage>. <comment>doi:10.2174/0929867054637617</comment>
<pub-id pub-id-type="pmid">16101497</pub-id></mixed-citation></ref><ref id="bibr14-0145561320950491"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Warnes</surname><given-names>SL</given-names></name><name><surname>Little</surname><given-names>ZR</given-names></name><name><surname>Keevil</surname><given-names>CW</given-names></name></person-group>
<article-title>Human coronavirus 229E remains infectious on common touch surface materials</article-title>. <source>mBio</source>. <year>2015</year>;<volume>6</volume>(<issue>6</issue>):<fpage>e01697</fpage>&#x02013;<lpage>15</lpage>. <comment>doi:10.1128/mBio.01697-15</comment>
<pub-id pub-id-type="pmid">26556276</pub-id></mixed-citation></ref><ref id="bibr15-0145561320950491"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>H</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name></person-group>, <etal>et al.</etal>
<article-title>Catalytic inactivation of SARS coronavirus, Escherichia coli and yeast on solid surface</article-title>. <source>Catal Commun</source>. <year>2004</year>;<volume>5</volume>(<issue>3</issue>):<fpage>170</fpage>&#x02013;<lpage>172</lpage>. <comment>doi:10.1016/j.catcom.2003.12.009</comment>
<pub-id pub-id-type="pmid">32288691</pub-id></mixed-citation></ref><ref id="bibr16-0145561320950491"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Andreou</surname><given-names>A</given-names></name><name><surname>Trantza</surname><given-names>S</given-names></name><name><surname>Filippou</surname><given-names>D</given-names></name><name><surname>Sipsas</surname><given-names>N</given-names></name><name><surname>Tsiodras</surname><given-names>S.</given-names></name></person-group>
<article-title>COVID-19: the potential role of copper and n-acetylcysteine (NAC) in a combination of candidate antiviral treatments against SARS-CoV-2</article-title>. <source>Vivo Athens Greece</source>. <year>2020</year>;<volume>34</volume>(<issue>3 suppl</issue>):<fpage>1567</fpage>&#x02013;<lpage>1588</lpage>.</mixed-citation></ref><ref id="bibr17-0145561320950491"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Inthavong</surname><given-names>K</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Shang</surname><given-names>Y</given-names></name></person-group>, <etal>et al.</etal>
<article-title>Geometry and airflow dynamics analysis in the nasal cavity during inhalation</article-title>. <source>Clin Biomech (Bristol, Avon)</source>. <year>2019</year>;<volume>66</volume>:<fpage>97</fpage>&#x02013;<lpage>106</lpage>. <comment>doi:10.1016/j.clinbiomech.2017.10.006</comment>
</mixed-citation></ref><ref id="bibr18-0145561320950491"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de Gabory</surname><given-names>L</given-names></name><name><surname>Reville</surname><given-names>N</given-names></name><name><surname>Baux</surname><given-names>Y</given-names></name><name><surname>Boisson</surname><given-names>N</given-names></name><name><surname>Bordenave</surname><given-names>L</given-names></name></person-group>
<article-title>Numerical simulation of two consecutive nasal respiratory cycles: toward a better understanding of nasal physiology: simulation of nasal physiology</article-title>. <source>Int Forum Allergy Rhinol</source>. <year>2018</year>;<volume>8</volume>(<issue>6</issue>):<fpage>676</fpage>&#x02013;<lpage>685</lpage>.<pub-id pub-id-type="pmid">29337433</pub-id></mixed-citation></ref><ref id="bibr19-0145561320950491"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>M</given-names></name><name><surname>Kleine-Weber</surname><given-names>H</given-names></name><name><surname>Schroeder</surname><given-names>S</given-names></name></person-group>, <etal>et al.</etal>
<article-title>SARS-CoV-2 Cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor</article-title>. <source>Cell</source>. <year>2020</year>;<volume>181</volume>(<issue>2</issue>):<fpage>271</fpage>&#x02013;<lpage>280</lpage>.e8.<pub-id pub-id-type="pmid">32142651</pub-id></mixed-citation></ref><ref id="bibr20-0145561320950491"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zou</surname><given-names>L</given-names></name><name><surname>Ruan</surname><given-names>F</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name></person-group>, <etal>et al.</etal>
<article-title>SARS-CoV-2 Viral load in upper respiratory specimens of infected patients</article-title>. <source>N Engl J Med</source>. <year>2020</year>;<volume>382</volume>(<issue>12</issue>):<fpage>1177</fpage>&#x02013;<lpage>1179</lpage>.<pub-id pub-id-type="pmid">32074444</pub-id></mixed-citation></ref><ref id="bibr21-0145561320950491"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fothergill</surname><given-names>JL</given-names></name><name><surname>Neill</surname><given-names>DR</given-names></name><name><surname>Loman</surname><given-names>N</given-names></name><name><surname>Winstanley</surname><given-names>C</given-names></name><name><surname>Kadioglu</surname><given-names>A</given-names></name></person-group>
<article-title>Pseudomonas aeruginosa adaptation in the nasopharyngeal reservoir leads to migration and persistence in the lungs</article-title>. <source>Nat Commun</source>. <year>2014</year>;<volume>5</volume>:<fpage>4780</fpage>
<comment>doi:10.1038/ncomms5780</comment>
<pub-id pub-id-type="pmid">25179232</pub-id></mixed-citation></ref><ref id="bibr22-0145561320950491"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Butowt</surname><given-names>R</given-names></name><name><surname>Bilinska</surname><given-names>K.</given-names></name></person-group>
<article-title>SARS-CoV-2: Olfaction, Brain infection, and the urgent need for clinical samples allowing earlier virus detection</article-title>. <source>ACS Chem Neurosci</source>. <year>2020</year>;<volume>11</volume>(<issue>9</issue>):<fpage>1200</fpage>&#x02013;<lpage>1203</lpage>. <comment>doi:10.1021/acschemneuro.0c00172</comment>
<pub-id pub-id-type="pmid">32283006</pub-id></mixed-citation></ref><ref id="bibr23-0145561320950491"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cabaillot</surname><given-names>A</given-names></name><name><surname>Vorilhon</surname><given-names>P</given-names></name><name><surname>Roca</surname><given-names>M</given-names></name><name><surname>Boussageon</surname><given-names>R</given-names></name><name><surname>Eschalier</surname><given-names>B</given-names></name><name><surname>Pereirad</surname><given-names>B</given-names></name></person-group>
<article-title>Saline nasal irrigation for acute upper respiratory tract infections in infants and children: a systematic review and meta-analysis</article-title>. <source>Paediatr Respir Rev</source>. <year>2020</year>;<comment>S1526&#x02013;0542(20)30016&#x02013;6</comment>
<comment>doi:10.1016/j.prrv.2019.11.003</comment>
</mixed-citation></ref><ref id="bibr24-0145561320950491"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>King</surname><given-names>D</given-names></name><name><surname>Mitchell</surname><given-names>B</given-names></name><name><surname>Williams</surname><given-names>CP</given-names></name><name><surname>Spurling</surname><given-names>GK</given-names></name></person-group>
<article-title>Saline nasal irrigation for acute upper respiratory tract infections</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2015</year>;(<issue>4</issue>):<fpage>CD006821</fpage>
<comment>doi:10.1002/14651858.CD006821.pub3</comment>
<pub-id pub-id-type="pmid">25892369</pub-id></mixed-citation></ref><ref id="bibr25-0145561320950491"><label>25</label><mixed-citation publication-type="web">
<comment>Participant Information Sheet. 2020</comment>
<comment>Accessed July 15, 2020</comment>
<ext-link ext-link-type="uri" xlink:href="https://www.ed.ac.uk/files/atoms/files/elvis_covid-19_participant_information_sheet_v4.0_01june2020.pdf">https://www.ed.ac.uk/files/atoms/files/elvis_covid-19_participant_information_sheet_v4.0_01june2020.pdf</ext-link>.</mixed-citation></ref><ref id="bibr26-0145561320950491"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ramalingam</surname><given-names>S</given-names></name><name><surname>Graham</surname><given-names>C</given-names></name><name><surname>Dove</surname><given-names>J</given-names></name><name><surname>Morrice</surname><given-names>L</given-names></name><name><surname>Sheikh</surname><given-names>A</given-names></name></person-group>
<article-title>A pilot, open labelled, randomised controlled trial of hypertonic saline nasal irrigation and gargling for the common cold</article-title>. <source>Sci Rep</source>. <year>2019</year>;<volume>9</volume>(<issue>1</issue>):<fpage>1015</fpage>
<comment>doi:10.1038/s41598-018-37703-3</comment>
<pub-id pub-id-type="pmid">30705369</pub-id></mixed-citation></ref><ref id="bibr27-0145561320950491"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mady</surname><given-names>LJ</given-names></name><name><surname>Kubik</surname><given-names>MW</given-names></name><name><surname>Baddour</surname><given-names>K</given-names></name><name><surname>Snyderman</surname><given-names>CH</given-names></name><name><surname>Rowan</surname><given-names>NR</given-names></name></person-group>
<article-title>. Consideration of povidone-iodine as a public health intervention for COVID-19: utilization as &#x000ab; Personal Protective Equipment &#x000bb; for frontline providers exposed in high-risk head and neck and skull base oncology care</article-title>. <source>Oral Oncol</source>. <year>2020</year>;<volume>105</volume>:<fpage>104724</fpage>.<pub-id pub-id-type="pmid">32317139</pub-id></mixed-citation></ref><ref id="bibr28-0145561320950491"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davidson</surname><given-names>TM</given-names></name><name><surname>Smith</surname><given-names>WM</given-names></name></person-group>
<article-title>The Bradford hill criteria and zinc-induced anosmia: a causality analysis</article-title>. <source>Arch Otolaryngol Head Neck Surg</source>. <year>2010</year>;<volume>136</volume>(<issue>7</issue>):<fpage>673</fpage>&#x02013;<lpage>676</lpage>.<pub-id pub-id-type="pmid">20644061</pub-id></mixed-citation></ref><ref id="bibr29-0145561320950491"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Rimmer</surname><given-names>J</given-names></name><name><surname>Mrad</surname><given-names>N</given-names></name><name><surname>Ahmadzada</surname><given-names>S</given-names></name><name><surname>Harvey</surname><given-names>RJ</given-names></name></person-group>
<article-title>Betadine has a ciliotoxic effect on ciliated human respiratory cells</article-title>. <source>J Laryngol Otol</source>. <year>2015</year>;<volume>129</volume>(<issue>suppl 1</issue>):<fpage>S45</fpage>&#x02013;<lpage>S50</lpage>. <comment>doi:10.1017/S0022215114002746</comment>
<pub-id pub-id-type="pmid">25363372</pub-id></mixed-citation></ref><ref id="bibr30-0145561320950491"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Challacombe</surname><given-names>SJ</given-names></name><name><surname>Kirk-Bayley</surname><given-names>J</given-names></name><name><surname>Sunkaraneni</surname><given-names>VS</given-names></name><name><surname>Combes</surname><given-names>J</given-names></name></person-group>
<article-title>Povidone iodine</article-title>. <source>Br Dent J</source>. <year>2020</year>;<volume>228</volume>(<issue>9</issue>):<fpage>656</fpage>&#x02013;<lpage>657</lpage>. <comment>doi:10.1038/s41415-020-1589-4</comment>
</mixed-citation></ref><ref id="bibr31-0145561320950491"><label>31</label><mixed-citation publication-type="web"><collab collab-type="author">Should You Still Rinse Your Sinuses During The COVID-19 Outbreak?</collab>
<year>2020</year>
<comment>Accessed July 15, 2020</comment>
<ext-link ext-link-type="uri" xlink:href="https://www.henryford.com/blog/2020/03/should-you-rinse-your-sinuses-during-covid">https://www.henryford.com/blog/2020/03/should-you-rinse-your-sinuses-during-covid</ext-link>.</mixed-citation></ref><ref id="bibr32-0145561320950491"><label>32</label><mixed-citation publication-type="web"><collab collab-type="author">Guidelines for Environmental Infection Control in Health-Care Facilities</collab>. <year>2003</year>
<comment>Accessed July 15, 2020</comment>
<ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/infectioncontrol/guidelines/environmental/appendix/air.html">https://www.cdc.gov/infectioncontrol/guidelines/environmental/appendix/air.html</ext-link>.</mixed-citation></ref><ref id="bibr33-0145561320950491"><label>33</label><mixed-citation publication-type="web"><collab collab-type="author">List N: Disinfectants for Use Against SARS-CoV-2 (COVID-19)</collab>. <comment>Accessed July 15, 2020</comment>
<ext-link ext-link-type="uri" xlink:href="https://www.epa.gov/pesticide-registration/list-n-disinfectants-use-against-sars-cov-2-covid-19">https://www.epa.gov/pesticide-registration/list-n-disinfectants-use-against-sars-cov-2-covid-19</ext-link>.</mixed-citation></ref></ref-list></back></article>